EZR and obstructive sleep apnea syndrome: As the phosphorylated (active) form of ezrin has been associated with pro-migratory and pro-invasive behaviour in both canine and human OSA, small molecule inhibitors have been focused on disrupting the phosphorylation site of ezrin and its ability to bind to F-actin.